Unknown

Dataset Information

0

Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy.

ABSTRACT:

SUBMITTER: Liu Y 

PROVIDER: S-EPMC10917735 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy.

Liu Yujie Y   Tu Yuqing Y   Xiao Jinyan J   Shen Yifan Y   Zhou Biqi B   Yang Qiannan Q   Yu Lei L   Qi Lijuan L   Chen Jia J   Liu Tianhui T   Wu Depei D   Xu Yang Y  

Blood cancer journal 20240306 1

Similar Datasets

Unknown Chronic myeloid leukemia: mechanisms of blastic transformation.
| S-EPMC2898591 | biostudies-literature
Unknown Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy.
| S-EPMC5728641 | biostudies-literature
Unknown Patients with CML in the lymphoid blastic phase have inferior response to anti-CD19 CAR T-cell therapy compared to de novo Ph-positive B cell acute lymphoblastic leukemia.
| S-EPMC10897941 | biostudies-literature
Unknown Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance.
| S-EPMC4140185 | biostudies-literature
Unknown Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib.
| S-EPMC4624459 | biostudies-literature
Unknown Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review.
| S-EPMC10725100 | biostudies-literature
Unknown Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia.
| S-EPMC2815702 | biostudies-literature
Unknown Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
| S-EPMC4134521 | biostudies-literature
Unknown Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia.
| S-EPMC5737170 | biostudies-literature
Unknown Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase.
| S-EPMC8367045 | biostudies-literature